REDHILL BIOPHARMA LTD-SP ADR (RDHL) Stock Income Statement
NASDAQ:RDHL - Nasdaq - US7574683014 - ADR - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 8.04M | 6.53M | 61.80M | 85.76M | 64.36M | |||
| Cost Of Goods | 3.19M | 3.46M | 33.34M | 40.51M | 36.09M | |||
| Gross Profit | 4.85M | 3.07M | 28.46M | 45.25M | 28.27M | |||
| Operating Expenses | 19.46M | -9.56M | 71.30M | 117.48M | 91.15M | |||
| Research and Development | 1.59M | 3.53M | 7.28M | 29.50M | 16.49M | |||
| Selling, General, and Administrative Expenses | 15.52M | 30.98M | 64.03M | 87.99M | 74.66M | |||
| Operating Income | -14.61M | 12.63M | -42.84M | -72.24M | -62.88M | |||
| Interest Income/Expense | 7.80M | -7.48M | -28.83M | -16.61M | -12.58M | |||
| Other Income/Expense | -1.46M | -1.82M | 0.00 | 0.00 | 90.00K | |||
| Non Recurring Items | 0.00 | 20.59M | N/A | -8.90M | -800.00K | |||
| Income Before Taxes | -8.27M | 23.92M | -71.67M | -97.74M | -76.17M | |||
| Net Income | -8.27M | 23.92M | -71.67M | -97.74M | -76.17M | |||
| EBITDA | -13.99M | 14.62M | -34.68M | -54.09M | -54.13M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.76 | 1.24K | -645.28 | -1.13K | -1.13K | |||
| Non GAAP EPS | N/A | N/A | N/A | -2.10K | -2.10K | |||
| Statistics | ||||||||
| Gross Profit Margin | 60.31% | 47.03% | 46.05% | 52.76% | 43.92% | |||
| Profit Margin | -102.80% | 366.25% | -115.97% | -113.97% | -118.35% | |||
| Operating Profit Margin | -181.69% | 193.45% | -69.32% | -84.24% | -97.70% | |||
All data in USD